Clinical and serological heterogeneity in patients with anticentromere antibodies

Journal of Rheumatology

Volumn 32, Issue 8, 2005, Pages 1488-1494

  Miyawaki, Shoji ^a,b   Asanuma, Hiroko ^a   Nishiyama, Susumu ^a   Yoshinaga, Yasuhiko ^a  

^a Kurashiki Medical Center   (Japan)

^b University of Tokyo   (Japan)

Author keywords

Anti CENP B antibodies; Anticentromere antibodies; CREST syndrome; Overlap syndrome; Sj gren's syndrome; Systemic sclerosis

Indexed keywords

CELL NUCLEUS ANTIGEN; CENTROMERE ANTIBODY; CENTROMERE PROTEIN B; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCINOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINGER MALFORMATION; GASTROESOPHAGEAL REFLUX; HEP 2 CELL; HUMAN; IMMUNODIFFUSION; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCLERODACTYLY; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CENTROMERE; CREST SYNDROME; FEMALE; HUMANS; INCIDENCE; LIVER CIRRHOSIS, BILIARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; SCLERODERMA, SYSTEMIC; SEROEPIDEMIOLOGIC STUDIES; SJOGREN'S SYNDROME;

EID: 23444449160     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relation to CREST syndrome. Arthritis Rheum 1980;23:617-25.
2. Fritzler MJ, Kinsella TD, Garbutt E. The CREST syndrome: A distinct serologic entity with anticentromere antibodies. Am J Med 1980;69:520-6.
3. Weiner ES, Earnshaw WC, Senecal J-L, Bordwell B, Johnson P, Rothfield N. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients. Arthritis Rheum 1988;31:378-85.
4. LeRoy EC, Krieg T, Black C, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-4.
5. Tramposch HD, Smith D, Senecal J-L, Rothfield N. A long-term longitudinal study of anticentromere antibodies. Arthritis Rheum 1984;27:121-4.
6. Vlachoyiannopoulos PG, Drosos AA, Wiik A, Moutsopoulos HM. Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol 1993;32:297-301.
7. Caramaschi P, Biasi D, Manzo T, Carletto A, Poli F, Bambara LM. Anticentromere antibody-clinical associations. A study of 44 patients. Rheumatol Int 1995;14:253-5.
8. Katano K, Kawano M, Koni I, Sugai S, Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. J Rheumatol 2001;28:2238-44.
9. Bernstein RM, Callender ME, Neuberger JM, Hughes GRV. Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis 1982;41:612-4.
10. Makinen D, Fritzler M, Davis P, Sherlock S. Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 1983;26:914-7.
11. McCarty GA, Rice JR, Bembe ML, Barada FA Jr. Anticentromere antibody. Clinical correlations and association with favorable prognosis in patients with scleroderma variants. Arthritis Rheum 1983;26:1-7.
12. Soma Y, Takehara K, Ishibashi Y. Clinical distribution of anticentromere antibody in Japanese patients. Dermatologica 1989;178:16-9.
13. Nakano M, Ohuchi Y, Hasegawa H, Kuroda T, Ito S, Gejyo F. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus. J Rheumatol 2000;27:1403-7.
14. Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS. The concurrence of rheumatoid arthritis and limited systemic sclerosis. Clinical and serological characteristics of overlap syndrome. Arthritis Rheum 1998;41:1938-45.
15. Zuber M, Gotzen R, Filler I. Clinical correlation of anticentromere antibodies. Clin Rheumatol 1994;13:427-32.
16. Kallenberg CG, Pastoor GW, Wouda AA, The TH. Antinuclear antibodies in patients with Raynaud's phenomenon. Clinical significance of anticentromere antibodies. Ann Rheum Dis 1982;41:282-7.
17. Miyawaki S, Tojo T. Classification criteria for Sjögren's syndrome in Japan. In: Homma M, Sugai S, editors. Sjögren's syndrome - State of the art. Amsterdam/New York: Kugler Publications; 1994:77-9.
18. Mimori T, Akizuki M, Yamagata H, Inada S, Yosida S, Homma M. Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J Clin Invest 1981;68:611-20.
19. Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue diseases and antinuclear antibodies. Amsterdam: Elsevier; 1987:41-7.
20. Clements PJ, Furst DE, Campion DS, et al. Muscle disease in progressive systemic sclerosis. Diagnostic and therapeutic consideration. Arthritis Rheum 1978;21:62-71.
21. Earnshaw W, Bordwell B, Marino C, Rothfield N. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies. J Clin Invest 1986;77:426-30.
22. Conrad K, Stahnke G, Liedvogel B, et al. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J Rheumatol 1995;22:1286-94.
23. Kuwana M, Kaburaki J, Arnett FC, Howard RF, Medsger TA Jr, Wright TM. Influence of ethnic background on clinical and serological features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999;42:465-74.
24. Jacobsen S, Halberg P, Ullman S, et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 1998;37:39-45.
25. Sato S, Ihn H, Soma Y, Shimozuma M, Shishiba T, Takehara K. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies. J Rheumatol 1993;20:1961-3.